BIOMAT Database Logo BIOMAT Database Logo

R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus. 1999

R D Berkowitz, and A B van't Wout, and N A Kootstra, and M E Moreno, and V D Linquist-Stepps, and C Bare, and C A Stoddart, and H Schuitemaker, and J M McCune
Gladstone Institute of Virology and Immunology, University of California at San Francisco, San Francisco, California, USA.

Some individuals infected with only R5 strains of human immunodeficiency virus type 1 progress to AIDS as quickly as individuals harboring X4 strains. We determined that three R5 viruses were much less pathogenic than an X4 virus in SCID-hu Thy/Liv mice, suggesting that R5 virus-mediated rapid disease progression is associated with host, not viral, factors.

UI MeSH Term Description Entries
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013950 Thymus Gland A single, unpaired primary lymphoid organ situated in the MEDIASTINUM, extending superiorly into the neck to the lower edge of the THYROID GLAND and inferiorly to the fourth costal cartilage. It is necessary for normal development of immunologic function early in life. By puberty, it begins to involute and much of the tissue is replaced by fat. Thymus,Gland, Thymus,Glands, Thymus,Thymus Glands
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016513 Mice, SCID Mice homozygous for the mutant autosomal recessive gene "scid" which is located on the centromeric end of chromosome 16. These mice lack mature, functional lymphocytes and are thus highly susceptible to lethal opportunistic infections if not chronically treated with antibiotics. The lack of B- and T-cell immunity resembles severe combined immunodeficiency (SCID) syndrome in human infants. SCID mice are useful as animal models since they are receptive to implantation of a human immune system producing SCID-human (SCID-hu) hematochimeric mice. SCID Mice,SCID-hu Mice,Severe Combined Immunodeficient Mice,Immunodeficient Mice, Severe Combined,Mouse, SCID,Mouse, SCID-hu,Mice, SCID-hu,Mouse, SCID hu,SCID Mouse,SCID hu Mice,SCID-hu Mouse
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D018450 Disease Progression The worsening and general progression of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis. Clinical Course,Clinical Progression,Disease Exacerbation,Exacerbation, Disease,Progression, Clinical,Progression, Disease

Related Publications

R D Berkowitz, and A B van't Wout, and N A Kootstra, and M E Moreno, and V D Linquist-Stepps, and C Bare, and C A Stoddart, and H Schuitemaker, and J M McCune
Noninfectious X4 but not R5 human immunodeficiency virus type 1 virions inhibit humoral immune responses in human lymphoid tissue ex vivo.
July 2004, Journal of virology,
R D Berkowitz, and A B van't Wout, and N A Kootstra, and M E Moreno, and V D Linquist-Stepps, and C Bare, and C A Stoddart, and H Schuitemaker, and J M McCune
Evolution of R5 and X4 human immunodeficiency virus type 1 gag sequences in vivo: evidence for recombination.
September 2003, Virology,
R D Berkowitz, and A B van't Wout, and N A Kootstra, and M E Moreno, and V D Linquist-Stepps, and C Bare, and C A Stoddart, and H Schuitemaker, and J M McCune
Frequent intrapatient recombination between human immunodeficiency virus type 1 R5 and X4 envelopes: implications for coreceptor switch.
April 2007, Journal of virology,
R D Berkowitz, and A B van't Wout, and N A Kootstra, and M E Moreno, and V D Linquist-Stepps, and C Bare, and C A Stoddart, and H Schuitemaker, and J M McCune
Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation.
April 2005, The Journal of general virology,
R D Berkowitz, and A B van't Wout, and N A Kootstra, and M E Moreno, and V D Linquist-Stepps, and C Bare, and C A Stoddart, and H Schuitemaker, and J M McCune
R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1.
September 2004, Journal of virology,
R D Berkowitz, and A B van't Wout, and N A Kootstra, and M E Moreno, and V D Linquist-Stepps, and C Bare, and C A Stoddart, and H Schuitemaker, and J M McCune
Both R5 and X4 human immunodeficiency virus type 1 variants persist during prolonged therapy with five antiretroviral drugs.
March 2002, Journal of virology,
R D Berkowitz, and A B van't Wout, and N A Kootstra, and M E Moreno, and V D Linquist-Stepps, and C Bare, and C A Stoddart, and H Schuitemaker, and J M McCune
Suppression of multiclade R5 and X4 human immunodeficiency virus type-1 infections by a coreceptor-based anti-HIV strategy.
November 2005, Journal of biochemistry,
R D Berkowitz, and A B van't Wout, and N A Kootstra, and M E Moreno, and V D Linquist-Stepps, and C Bare, and C A Stoddart, and H Schuitemaker, and J M McCune
CD40-activated macrophages become highly susceptible to X4 strains of human immunodeficiency virus type 1.
January 2002, AIDS research and human retroviruses,
R D Berkowitz, and A B van't Wout, and N A Kootstra, and M E Moreno, and V D Linquist-Stepps, and C Bare, and C A Stoddart, and H Schuitemaker, and J M McCune
R5 to X4 coreceptor switch of human immunodeficiency virus type 1 B' and B'/C recombinant subtype isolates in China.
March 2007, Chinese medical journal,
R D Berkowitz, and A B van't Wout, and N A Kootstra, and M E Moreno, and V D Linquist-Stepps, and C Bare, and C A Stoddart, and H Schuitemaker, and J M McCune
Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4+ cells.
March 2004, Journal of virology,
Copied contents to your clipboard!